Preclinical biotech developing oral integrin inhibitors for chronic diseases.
Industry: Health Care
First Day Return: +20.0%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 05/30/2019 |
Offer Price | $15.00 |
Price Range $14.00 - $16.00 | |
Offer Shares (mm) | 6.0 |
Deal Size ($mm) | $90 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 06/26/2019 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $90 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Waltham, MA, United States |
Founded | 2014 |
Employees at IPO | 65 |
Website www.morphictx.com |